<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Qian C</submitter><funding>NCI NIH HHS</funding><pagination>181-189</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8832285</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>530</volume><pubmed_abstract>The ETS family of proteins consists of 28 transcription factors, many of which play critical roles in both normal tissue development and homeostasis and have been implicated in development and progression of a variety of cancers. In prostate cancer, gene fusion and overexpression of ETS factors ERG, FLI1, ETV1, ETV4 and ETV5 have been found in half of prostate cancer patients in Caucasian men and define the largest genetic subtype of prostate cancer. This review summarizes the data on the discovery, modeling, molecular taxonomy, lineage plasticity and therapeutic targeting of ETS family members in prostate cancer.</pubmed_abstract><journal>Cancer letters</journal><pubmed_title>ETS factors in prostate cancer.</pubmed_title><pmcid>PMC8832285</pmcid><funding_grant_id>P50 CA092629</funding_grant_id><funding_grant_id>U54 CA224079</funding_grant_id><funding_grant_id>P30 CA008748</funding_grant_id><funding_grant_id>K08 CA140946</funding_grant_id><funding_grant_id>R01 CA208100</funding_grant_id><funding_grant_id>U01 CA224044</funding_grant_id><funding_grant_id>R01 CA193837</funding_grant_id><pubmed_authors>Qian C</pubmed_authors><pubmed_authors>Li D</pubmed_authors><pubmed_authors>Chen Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>ETS factors in prostate cancer.</name><description>The ETS family of proteins consists of 28 transcription factors, many of which play critical roles in both normal tissue development and homeostasis and have been implicated in development and progression of a variety of cancers. In prostate cancer, gene fusion and overexpression of ETS factors ERG, FLI1, ETV1, ETV4 and ETV5 have been found in half of prostate cancer patients in Caucasian men and define the largest genetic subtype of prostate cancer. This review summarizes the data on the discovery, modeling, molecular taxonomy, lineage plasticity and therapeutic targeting of ETS family members in prostate cancer.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2025-04-26T13:15:04.254Z</modification><creation>2025-04-06T14:09:24.642Z</creation></dates><accession>S-EPMC8832285</accession><cross_references><pubmed>35033589</pubmed><doi>10.1016/j.canlet.2022.01.009</doi></cross_references></HashMap>